Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
1
0
0
0
KINETA INC. Share · US49461C1027 · KA · A3D2GA (XNCM) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of KINETA INC.
Analyst Grade Summary
No Price
Share Float & Liquidity
Free Float 65,11 %
Shares Float 7,98 M
Shares Outstanding 12,26 M
Company Profile for KINETA INC. Share
Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.
Company Data
Name KINETA INC.
Company Kineta, Inc.
Symbol KA
Website
https://kinetabio.com
Primary Exchange 
Frankfurt
Frankfurt
WKN A3D2GA
ISIN US49461C1027
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Craig W. Philips
Country United States of America
Currency EUR
Employees 0,0 T
Address 219 Terry Ave. N, 98109 Seattle
IPO Date 2016-02-11
Dividends from 'KINETA INC.'
| Ex-Date | Dividend per Share |
|---|---|
| 19.12.2022 | 1,43 USD |
Stock Splits
| Date | Split |
|---|---|
| 19.12.2022 | 1:7 |
| 23.12.2020 | 1:20 |
ID Changes
| Date | From | To |
|---|---|---|
| 19.12.2022 | YMTX | KA |
| 23.12.2020 | PTI | YMTX |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | KA |
More Shares
Investors who hold KINETA INC. also have the following shares in their portfolio:
